Pharmaceutical Industry Information Portal

HomeNews

News

Investors concerned about monkeypox have already begun to raise their stock prices

Cases of monkeypox have been identified in several European countries Spain, Portugal, the United Kingdom, as well as in the United States, Canada and...

U.S.FDA lifts ban on COVAXIN Covid-19 vaccine candidate study

Ocugen, Inc., a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, May 23th announced that the U.S. Food...

Merck KGaA invests about €440 million to expand production in Ireland

Merck KGaA said Monday that it would invest about 440 million euros ($464.8 million) to expand manufacturing in membrane and filtration, as part of...

Bayer intends to discontinue partnership with Atara on CAR-T for $670 million

Atara Biotherapeutics, Inc., a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and...

Cases of monkeypox are being investigated in Europe, the United States, Canada, and Australia

Cases of monkeypox are being investigated in several European countries as well as the US, Canada and Australia, according to health authorities and local...

Viatris and Biocon Biologics launch Abevmy, oncology biosimilar, in Canada

Viatris Inc. and Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced May 19th, that Abevmy® (bevacizumab) is now available in Canada. Abevmy, co-developed...
spot_img

Expert Articles

spot_img